OptiNose, Inc. Uncategorized Contracts & Agreements

12 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Third Amendment to t
OptiNose, Inc.
2024
Second Amendment to the
OptiNose, Inc.
2024
Description of Securities of OptiNose, Inc
OptiNose, Inc.
2024
Description of Securities of OptiNose, Inc
OptiNose, Inc.
Pharmaceuticals
2023
Open Market Sale Agreement (the Sale Agreement), dated August 11, 2021, between the Company and Jefferies LLC
OptiNose, Inc.
Pharmaceuticals
NY
2021
Open Market Sale Agreement (the Sale Agreement), dated August 11, 2021, between the Company and Jefferies LLC
OptiNose, Inc.
Pharmaceuticals
NY
2021
Description of Securities of OptiNose, Inc
OptiNose, Inc.
Pharmaceuticals
2020
Stockholders' Agreement, dated October 2, 2017, by and among OptiNose, Inc. and certain of its stockholders
OptiNose, Inc.
Pharmaceuticals
NY
2017
Letter Agreement, dated as of January 13, 2017, by and between OptiNose US, Inc. and Michael F. Marino
OptiNose, Inc.
Pharmaceuticals
DE
2017
Letter Agreement, dated as of January 13, 2017, by and between OptiNose US, Inc. and Keith A. Goldan
OptiNose, Inc.
Pharmaceuticals
DE
2017
Letter Agreement, dated as of September 15, 2016, by and between OptiNose US, Inc. and Thomas E. Gibbs
OptiNose, Inc.
Pharmaceuticals
DE
2017
Letter Agreement, dated as of June 18, 2010, by and between the Registrant and Ramy A. Mahmoud
OptiNose, Inc.
Pharmaceuticals
DE
2017